Company Comparison
Tyra Biosciences vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Tyra Biosciences | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Carlsbad, California | Lagos, Nigeria |
| Founded | 2018 | 2019 |
| Status | Active | Active |
| Last Funding Stage | IPO | Series B |
| Total Funding | $200M | $45M |
| Valuation | — | — |
What They Build
Tyra Biosciences
Precision oncology company developing targeted therapies for patients with cancer driven by specific genetic alterations.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Tyra Biosciences
Sector Overlap
Both Tyra Biosciences and 54gene operate in Biotech.
Browse all Biotech companies →Sponsored
AArchstone
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees
Now in alpha with select funds. 14-day trial available.